IGC Pharma Inc (IGC)
0.447
+0.02
(+3.95%)
USD |
NYAM |
Apr 26, 16:00
0.48
+0.03
(+7.38%)
After-Hours: 20:00
IGC Pharma Accounts Receivable (Quarterly): 0.092M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.092M |
September 30, 2023 | 0.137M |
June 30, 2023 | 0.225M |
March 31, 2023 | 0.107M |
December 31, 2022 | 0.251M |
September 30, 2022 | 0.189M |
June 30, 2022 | 0.147M |
March 31, 2022 | 0.125M |
December 31, 2021 | 0.164M |
September 30, 2021 | 0.138M |
June 30, 2021 | 0.162M |
March 31, 2021 | 0.175M |
December 31, 2020 | 0.226M |
September 30, 2020 | 0.241M |
June 30, 2020 | 0.264M |
March 31, 2020 | 0.133M |
December 31, 2019 | 0.155M |
September 30, 2019 | 0.244M |
June 30, 2019 | 0.189M |
March 31, 2019 | 0.084M |
December 31, 2018 | 0.201M |
September 30, 2018 | 0.162M |
June 30, 2018 | 1.988M |
March 31, 2018 | 0.558M |
December 31, 2017 | 1.155M |
Date | Value |
---|---|
September 30, 2017 | 1.034M |
June 30, 2017 | 0.8395M |
March 31, 2017 | 0.7529M |
December 31, 2016 | 0.663M |
September 30, 2016 | 0.654M |
June 30, 2016 | 0.5916M |
March 31, 2016 | 0.9627M |
December 31, 2015 | 0.7618M |
September 30, 2015 | 1.095M |
June 30, 2015 | 1.025M |
March 31, 2015 | 0.9933M |
December 31, 2014 | 0.9477M |
September 30, 2014 | 1.215M |
June 30, 2014 | 1.108M |
March 31, 2014 | 0.5663M |
December 31, 2013 | 0.8901M |
September 30, 2013 | 0.9857M |
June 30, 2013 | 0.9618M |
March 31, 2013 | 1.067M |
December 31, 2012 | 0.5886M |
September 30, 2012 | 1.574M |
June 30, 2012 | 1.451M |
March 31, 2012 | 1.642M |
December 31, 2011 | 5.972M |
September 30, 2011 | 2.381M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.092M
Minimum
Dec 2023
0.264M
Maximum
Jun 2020
0.1771M
Average
0.164M
Median
Dec 2021
Accounts Receivable (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -- |
NovaBay Pharmaceuticals Inc | 0.759M |
Protalix BioTherapeutics Inc | 5.272M |
Palatin Technologies Inc | 2.346M |